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Opioid Consumption After Knee Arthroscopy
Robert D. Wojahn, MD, Ljiljana Bogunovic, MD, Robert H. Brophy, MD, Rick W. Wright, MD, Matthew J. Matava, MD,
John R. Green IV, BS, Corinne A. Zalomek, BA, Amanda K. Haas, MA, Wendy L. Holloway, BS, Elizabeth A. Garofoli, and
Matthew V. Smith, MD
Investigation performed at the Department of Orthopaedic Surgery, Washington University in St. Louis, St. Louis, Missouri

Background: The opioid epidemic in the United States has placed increased pressure on physicians to engage in
responsible opioid prescribing practices. However, surgeons currently have little information to guide their postoperative
prescription decision-making. The purpose of this study was to assess opioid consumption after knee arthroscopy and
identify preoperative factors that may predict higher opioid usage.
Methods: A prospective observational study of 221 patients was conducted in patients undergoing outpatient knee
arthroscopy for meniscal repair, partial meniscectomy, debridement, chondroplasty, or loose body removal. Participants
recorded their daily opioid consumption in a postoperative pain diary. Total opioid consumption was calculated from
counts of remaining pills at the 2-week and 6-week postoperative ofﬁce visits. Variables, including age, sex, body mass
index, smoking status, alcohol consumption, preoperative pain severity and duration, preoperative opioid usage, PatientReported Outcomes Measurement Information System (PROMIS) scores, and the Connor-Davidson Resilience Scale,
were evaluated for an association with opioid consumption.
Results: Total opioid consumption ranged from 0 to 188 pills, with a median of 7 pills (hydrocodone 5-mg equivalents).
Forty-six percent of patients took £5 pills, 59% took £10 pills, and 81% took £20 pills. Fifty-six percent of patients had
discontinued opioid usage by the third postoperative day. Eighty-eight percent of patients had surplus opioid medication at
the time of the ﬁnal follow-up. Patients undergoing meniscal repair, smokers, and those taking preoperative opioids were
signiﬁcantly more likely to take ‡20 pills (p < 0.05).
Conclusions: The median number of pills taken after knee arthroscopy is 7, with the majority of patients consuming
£20 pills. Meniscal repair, smoking, and preoperative opioid usage were associated with higher postoperative opioid
consumption.
Level of Evidence: Prognostic Level IV. See Instructions for Authors for a complete description of levels of evidence.

P

rescription opioid use in the United States quadrupled
from 1999 to 20151. Paralleling this trend has been a
nearly identical rise in opioid-related morbidity and
mortality2,3. In 2015, opioids were responsible for over 33,000
drug overdose deaths, with half of these due to prescription
opioids1. Alarmingly, the United States now accounts for 80%
of total opioid consumption and 99% of hydrocodone use
despite comprising only 5% of the world’s population4.
Emphasis on quality-of-care metrics such as pain control
and patient satisfaction may create an incentive for physicians to
overprescribe5. Furthermore, with the rescheduling of hydrocodone as a Schedule-II controlled substance in 2014, larger

prescriptions may be written to avoid return patient trips to the
ofﬁce to reﬁll prescriptions. The result is potentially a surplus of
prescription opioid medication available for diversion and
abuse. More than half of non-medical opioid users obtain their
drugs from a friend or family member and prescription opioid
medication may serve as a gateway drug for the majority of
heroin users6,7. Therefore, reducing the availability of prescription opioids on a population level could combat this trend of
rising narcotic abuse2.
Orthopaedic surgeons play an important role in this effort
as the third highest prescribers of opioids in the United States8.
Knee arthroscopy is one of the most commonly performed
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Grant UL1 TR000448 and Siteman Comprehensive Cancer Center and NCI Cancer Center Support Grant P30 CA091842. On the Disclosure of Potential
Conﬂicts of Interest forms, which are provided with the online version of the article, one or more of the authors checked “yes” to indicate that the author
had a relevant ﬁnancial relationship in the biomedical arena outside the submitted work (http://links.lww.com/JBJS/E859).
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Patients completed a preoperative questionnaire at the
time of enrollment with regard to smoking status, alcohol
consumption, psychiatric medication usage, preoperative pain
severity and duration, preoperative opioid and non-opioid

TABLE I Preoperative Patient Characteristics
Characteristic
Age* (yr)

Value
46.2 (14 to 76)

Sex†
Male

114 (51.6%)

Female

107 (48.4%)

Weight* (kg)
Fig. 1

Flow diagram of study enrollment.

BMI*

(kg/m2)

Materials and Methods
ollowing institutional review board approval, a prospective
observational study was conducted for patients undergoing
outpatient knee arthroscopy at a single academic medical center
between May 2016 and June 2017. Procedures eligible for
inclusion were meniscal repair (both all-inside and inside-out
repairs), partial meniscectomy, loose body removal, debridement, and chondroplasty. Exclusion criteria were age of <12
years (these patients are ineligible for a surgical procedure at
our outpatient surgery center), a revision surgical procedure,
preoperative opioid consumption of >1 month, or Workers’
Compensation cases. The last 3 criteria were chosen because
these are patients known to require higher doses of opioid
medication after a surgical procedure and we believed that this
could skew results9.
Five hundred patients were approached for study enrollment, of whom 286 patients consented to participation. Sixtyﬁve patients did not meet inclusion criteria, including 23 patients
who had missing data preventing determination of total opioid
consumption, 16 patients who underwent a procedure ineligible
for the study, and 2 patients who had their surgical procedures
cancelled after initial enrollment (Fig. 1). All patients for whom
the total number of opioid pills consumed was ascertainable
from the collected data were included in the ﬁnal analysis,
regardless of other missing data. The ﬁnal data analysis involved
221 patients, including 11 minors (14 to 17 years of age).

F

29.0 (17.2 to 70.0)

Smoking status†
Nonsmokers

surgical procedures and thus an ideal target for curtailing excessive postoperative opioid prescriptions. However, surgeons
currently have little objective data to guide their postoperative
prescribing practices and are frequently forced to make an educated guess with regard to opioid consumption.
The purpose of this prospective study was to assess the
pattern of total opioid consumption after knee arthroscopy and
to identify preoperative factors predictive of higher opioid
consumption. Such information could guide the appropriate
prescribing of opioid medications after knee arthroscopy.

87.8 (49.9 to 181.9)

212 (95.9%)

Smokers

8 (3.6%)

Not reported

1 (0.5%)

Alcohol use†
Never

39 (17.6%)

<1 time/mo

44 (19.9%)

<1 time/wk

36 (16.3%)

1 to 3 times/wk

72 (32.6%)

>3 to 6 times/wk

21 (9.5%)

Daily

9 (4.1%)

Psychiatric medication†
No
Yes
Not reported
VAS knee pain severity*
(0 to 100) (points)

173 (78.3%)
39 (17.6%)
9 (4.1%)
39.5 (0 to 100)

Knee pain duration†
1 wk to 1 mo

24 (10.9%)

>1 to 3 mo

59 (26.7%)

>3 to 6 mo

42 (19.0%)

>6 to 24 mo

63 (28.5%)

>24 mo

29 (13.1%)

Not reported

4 (1.8%)

Preoperative opioid usage† (<1 mo)
No

215 (97.3%)

Yes

6 (2.7%)

Connor-Davidson Resilience
Scale score*‡ (points)

33.1 (13 to 40)

PROMIS scores*
Anxiety

47.4 (32.9 to 71.6)

Depression

43.6 (34.0 to 68.7)

Pain interference

60.1 (38.6 to 75.3)

Physical function

41.1 (20.0 to 73.0)

*The values are given as the mean, with the range in parentheses. †The
values are given as the number of patients, with the percentage in
parentheses. ‡In this score, 0 is the least resilient and 40 is the most
resilient.
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analgesic use, and the Connor-Davidson Resilience Scale10,11,
which assesses one’s ability to cope with stress. The ConnorDavidson Resilience Scale remained valid and was included for
all patients who responded to at least 9 of the 10 questions.
No modiﬁcations were made to surgeons’ intraoperative
and postoperative procedures or protocols in this observational
study. Speciﬁcally, local anesthetic injections at case conclusion, postoperative weight-bearing restrictions, and analgesic
prescriptions were left to the discretion of the attending
surgeon. Additionally, patients were permitted to use any
over-the-counter non-opioid analgesics as necessary. All procedures were performed under general anesthesia by 1 of 5
fellowship-trained orthopaedic sports medicine surgeons with
participation of a fellow or resident. Surgical procedures were
performed at a single orthopaedic-only outpatient center with
a consistent team of anesthesiologists and nurses. Although the
perioperative pain management instructions were not speciﬁcally controlled for this investigation, the interpatient variability was minimal.
Following the surgical procedure, patients completed a
daily pain diary documenting their mean pain level on a visual
analog scale (VAS) scored on a continuum from 0 to 100 points
and pain medication consumption, both opioid and nonopioid analgesics. Data were logged each day for the ﬁrst 7 days
and on the day of the ﬁrst postoperative ofﬁce visit, typically 10
to 14 days after the procedure. At both the 2-week and 6-week
postoperative ofﬁce visits, patients completed a questionnaire
with regard to the number of opioid pills remaining in their last
bottle, whether they were still taking opioid pain medication,
and overall satisfaction with the postoperative pain control
regimen on a VAS of 0 to 100 points. Patients were asked to
bring their opioid pill bottles to the ofﬁce for counts to be
veriﬁed by research staff. All opioid pills were converted to an
equivalent number of hydrocodone 5-mg pills for ease of
analysis and interpretation12.
The medical record was reviewed for demographic information, preoperative Patient-Reported Outcomes Measurement
Information System (PROMIS) scores (anxiety, depression, pain
interference, and physical function), type and quantity of opioid
and non-opioid pills prescribed, number and quantity of reﬁlls
provided, and the use of a postoperative regional anesthetic
block.

for inclusion in stepwise regression. Patients with missing data
for predictive variables were excluded from regression analyses in
a list-wise deletion fashion. Predictive variables were checked for
multicollinearity using Pearson or Spearman correlation coefﬁcients, as appropriate for their distribution. Those with values of
>0.7 were analyzed in separate stepwise regressions and model ﬁt
statistics were utilized to determine which variable to include in
the ﬁnal model. Variables from the stepwise analysis with p <
0.05 were included in the ﬁnal logistic regression model.
Results
able I outlines the distribution of baseline variables including smoking status, psychiatric medication usage, preoperative pain severity and duration, and preoperative opioid
consumption (<1 month). Table II shows the distribution of
surgical variables including primary surgical procedure, initial

T

TABLE II Distribution of Surgical Variables*
Variable

No. of Patients

Primary surgical procedure
Partial meniscectomy
Meniscal repair
All-inside
Inside-out
Chondroplasty
Loose body removal
Debridement

170 (76.9%)
13 (5.9%)
11
2
19 (8.6%)
14 (6.3%)
5 (2.3%)

Initial opioid prescription
Hydrocodone

214 (96.8%)

Oxycodone

2 (0.9%)

Tramadol

2 (0.9%)

Codeine

3 (1.4%)

Initial prescription size
20 pills

68 (30.8%)

30 pills

5 (2.3%)

40 pills
50 pills

98 (44.3%)
41 (18.6%)

60 pills

9 (4.1%)

NSAID prescription

Statistical Analysis
Data were analyzed with descriptive statistics to determine the
frequency for categorical variables and the mean, standard
deviation, median, and quartiles for continuous variables, as
appropriate for their distribution. The association between
procedure type, site of local anesthetic injection, or initial
prescription size and outcome variables was analyzed using the
Kruskal-Wallis test.
Logistic regression analysis was then performed to identify
predictors of low opioid consumption (<20 pills) compared with
high opioid consumption (‡20 pills). Univariate logistic regression analysis was ﬁrst conducted to determine predictive variables (deﬁned as those with p < 0.1) of total opioid consumption

Yes

132 (59.7%)

No

89 (40.3%)

Local anesthetic use
Portals only
Intra-articular

98 (44.3%)
123 (55.7%)

Regional anesthesia block
None
Single shot block
Continuous catheter

218 (98.6%)
1 (0.5%)
2 (0.9%)

*The values are given as the number of patients, with the percentage in parentheses.
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Fig. 2

Distribution of total postoperative opioid consumption at the time of the ﬁnal follow-up (converted to hydrocodone 5-mg equivalents).

opioid prescription size, and prescription for a nonsteroidal
anti-inﬂammatory drug (NSAID).
Total opioid consumption ranged from 0 to 188 pills, with
a median of 7 pills (hydrocodone 5-mg equivalents) (Fig. 2 and
Table III). Forty-six percent of patients took £5 pills, 59% of
patients took £10 pills, and 81% of patients took £20 pills. The
single patient who took 188 pills represented an outlier (the next
highest value was only 90 pills), and was excluded from the
remainder of the analysis to prevent bias of results.
Of 221 patients, 191 (86.4%) completed the postoperative pain diary recording their daily opioid and non-opioid
analgesic use. Of these 191 patients, 56% had discontinued
opioid use by postoperative day 3 and 76%, by postoperative
day 5 (Fig. 3). Seventy-three patients recorded taking a prescribed anti-inﬂammatory medication and 82 patients took an
over-the-counter analgesic. Total opioid consumption was no
different in those who took a prescribed anti-inﬂammatory or
any over-the-counter analgesic compared with those who did
not (p = 0.36). Patient satisfaction with their pain management
regimen was high, with a range from 0 to 100 points and
median of 97 points.
One hundred and eighty patients (81.4%) brought their
pills to the ofﬁce for research staff to count and the remainder
had a self-reported pill count. Ninety-eight patients had both
self-reported and staff counts, of which 83 (84.7%) reported
identical counts, 10 differed by 1 to 10 pills, and 5 differed by 11
to 20 pills. At the time of the ﬁnal follow-up, 194 patients
(87.8%) had surplus opioid medication. Twenty-seven patients
(12.2%) completed their initial prescription, but only 13
patients (5.9%) obtained a reﬁll. Comparing patients who
received an initial opioid prescription for 20 pills, 30 to 40
pills, and ‡50 pills, the percentage of patients obtaining reﬁlls

decreased from 10.3% to 4.9% to 2.0% with each increased
initial prescription size, but ﬁnal patient satisfaction did not
differ between the groups (p = 0.23). Sixteen percent of
patients were still taking opioids at the 2-week postoperative
visit, and 6.2% of patients were still taking opioids at the

TABLE III Distribution of Total Opioid Consumption
(Hydrocodone 5-mg Equivalents)
No. of Pills Taken

Percentage

Cumulative Percentage
17.6

0

17.6

1 to 5

28.1

45.7

6 to 10

13.1

58.8

11 to 15

12.2

71.0

16 to 20

9.5

80.5

21 to 25

3.2

83.7

26 to 30

2.7

86.4

31 to 35

1.4

87.8

36 to 40

5.4

93.2

41 to 45

1.4

94.6

46 to 50

1.4

95.9

51 to 55

0.5

96.4

56 to 60

1.4

97.7

61 to 65

0.0

97.7

66 to 70

0.5

98.2

71 to 75

0.5

98.6

76 to 80

0.5

99.1

>80

0.9

100.0
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Fig. 3

Percent of patients taking opioids, mean VAS pain score, and mean opioid consumption for each postoperative day (POD). POV = postoperative visit.

6-week postoperative ofﬁce visit. Patients undergoing meniscal
repair took signiﬁcantly more pills than those undergoing
other procedures (p = 0.006) (Fig. 4).
Predictors of higher opioid consumption (‡20 pills)
included meniscal repair compared with other procedures
(odds ratio [OR], 7.9 [95% conﬁdence interval (CI), 1.8 to

35.7]), smoking (OR, 11.9 [95% CI, 2.0 to 71.7]), and preoperative opioid use (OR, 7.7 [95% CI, 1.2 to 50.0]). However, the interpretation of these values is somewhat limited
by small sample sizes, with 13 meniscal repairs, 8 smokers,
and 6 preoperative opioid users. Despite the number of predictive variables analyzed, R2 for the ﬁnal logistic regression

Fig. 4

Box-and-whisker plot showing the minimum, lower quartile, median (junction of the blue and orange boxes), upper quartile, and maximum total opioid
consumption for each surgical procedure.
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Fig. 5

Percentage of patients who would require a reﬁll and the mean surplus pills per patient for a range of hypothetical initial prescription sizes.

model was only 0.21. No association was seen between age,
sex, weight, body mass index (BMI), alcohol consumption,
psychiatric medication usage, preoperative pain severity
or duration, PROMIS scores, Connor-Davidson Resilience
Scale score, site of local anesthetic injection, postoperative
NSAID prescription, or over-the-counter analgesic use
and total opioid consumption in the logistic regression
analysis.
From the data, we calculated the percentage of patients
who would have a required an opioid reﬁll and the mean
number of surplus pills per patient if a range of hypothetical
initial prescription sizes had been given to all patients (Fig. 5).
For example, if all patients were given an initial prescription of
30 pills, approximately 15% would require a reﬁll, but the mean
patient would have 20 surplus pills.
Discussion
fter knee arthroscopy, nearly 50% of patients took £5 pills
and approximately 80% took £20 pills. More than half of
the patients had discontinued opioid use by the third postoperative day. Patient satisfaction was not associated with initial
prescription size. Not surprisingly, smaller prescription sizes
resulted in fewer surplus pills potentially available for diversion
but at the expense of necessitating a greater number of reﬁlls for
the prescribing surgeon. We did not standardize physicians’
responses to reﬁll requests because this was an observational
study. Considering that Figure 5 may overestimate actual reﬁll
rates because not all patients who complete their prescription
will obtain a reﬁll, we conclude that routine prescriptions in
excess of 30 pills are unnecessary and a smaller amount such as
15 or 20 pills is likely appropriate except for meniscal repair
procedures.

A

Patients undergoing meniscal repair, smokers, and those
taking opioids preoperatively, even for <1 month, are more
likely to take ‡20 pills after the surgical procedure. We suspect
that the higher opioid requirement for meniscal repair is due to
suture placement through the well-innervated capsular tissue.
Only 2 of the repairs were performed with an inside-out
technique, so we do not believe that the additional incision or
soft-tissue dissection played a major role in the increased
opioid usage. Physiological changes that may develop from
smoking and preoperative opioid use may increase the need for
opioid use after a surgical procedure. Both animal and functional imaging studies have suggested an interaction between
nicotine and the endogenous opioid system with nicotine
stimulating mu-receptor neurotransmission13. Our logistic
regression model only explains 21% of the variance, suggesting
that the prediction of patients likely to require higher amounts
of opioids remains incompletely understood. This is similar to
the ﬁndings of Grant et al.14, whose multivariate regression
model only explained half of the variance in opioid consumption in adolescents undergoing spine surgery. It remains
unclear what factors affect pain tolerance, but the present study
serves as a ﬁrst step in understanding this important clinical
issue by establishing rough guidelines for typical usage and
highlighting the need for further investigation into factors
associated with opioid use in these patients.
The results of the present study add to an increasing body
of literature on postoperative opioid consumption in orthopaedic surgery. A recently published investigation of patients
undergoing operative ﬁxation of distal radial fractures found a
mean opioid consumption of 14.6 oxycodone 5-mg tablets
for a mean duration of 4.8 days after the surgical procedure15.
In that study, younger patients, those without insurance, and
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patients with public aid consumed higher levels of opioids
after the surgical procedure. In our study, 56% of patients
discontinued opioid consumption by postoperative day 3 and
81% discontinued by postoperative day 7. Our current study
and that by O’Neil et al. suggest that the majority of patients
undergoing a procedure with a predictable level of pain (mild
to moderate) will likely not require opioid medication beyond
1 week after the surgical procedure. Kim et al.16 and Rodgers
et al.17 reported a mean consumption of 8 to 10 pills in patients
undergoing an upper-extremity surgical procedure, with
patients undergoing soft-tissue procedures requiring signiﬁcantly fewer opioid pills than those undergoing bone or joint
procedures (p < 0.05). Half of their patients required opioid
medication for only 2 days after the surgical procedure.
Investigations in the orthopaedic trauma literature have highlighted the importance of socioeconomic status in predicting
postoperative opioid consumption, with unemployed, lowerincome, and less-educated patients more likely to believe that
they were underprescribed pain medication and seek additional opioid medication beyond that prescribed by their
surgeon18,19.
We did not observe an association between psychiatric
mediation usage, PROMIS scores, or Connor-Davidson Resilience Scale scores and opioid consumption. In contrast, Helmerhorst et al. found that patients who scored higher on
catastrophic thinking, anxiety, and depression questionnaires
were signiﬁcantly more likely to take opioid medication 1 to 2
months after the surgical procedure for orthopaedic trauma
regardless of injury severity, fracture location, or treating surgeon20. Some of this may reﬂect differences in the experience of
trauma surgery compared with elective knee surgery as well as
the overall demographic characteristics of these patient populations. Moreover, this association of mental health and
coping mechanisms with opioid usage remains a difﬁcult factor
to measure or quantify.
There were several limitations of this study. First, patients
were not blinded to their participation or the study aims and
may have reduced their opioid consumption in an effort to
appear tough to the treating surgeon. We attempted to mitigate
this effect by excluding surgeons from data collection or pill
counting. Although >80% of the patients had a recorded pill
count by a research staff member, the self-reported pill counts
of the remaining patients may be prone to bias. However, an
analysis of a sample of patients with both counts suggests
discrepancies between the 2 counts were minimal. Additionally,
we did not limit over-the-counter medications that may have
inﬂuenced opioid consumption. However, we observed no
difference in opioid consumption in those who documented
use of these medications in their pain diary. Our requirement
that total postoperative opioid consumption be ascertainable
may have excluded patients who obtained multiple reﬁlls or
several different opioid prescriptions, as these patients’ opioid
consumption was more difﬁcult to track and there was no
opioid-monitoring program in our state at the time of the
study. The selection bias involving patients who agreed to study
participation may have inﬂuenced our results if these patients

differed systematically from those who declined enrollment.
Additionally, our suburban study location resulted in few
underinsured or low-socioeconomic-status patients being
enrolled, which is a group known to require higher levels
of opioids after orthopaedic procedures18,19. Some surgical
variability may have occurred within our procedure groupings
for which we were unable to account. There may also have been
other variables predictive of opioid consumption that we
did not measure or control, such as perioperative pain
management counseling and osteoarthritis grade at the time of
arthroscopy. We did not include a radiographic or arthroscopic
osteoarthritis grade as a statistical variable in our analysis
because there were not enough patients with each grade of
cartilage degeneration to provide a meaningful analysis of its
effect on opioid consumption. Finally, we did not enroll
patients who had been taking preoperative opioids longer than
1 month. Consequently, we are unable to comment on postoperative opioid consumption in patients with chronic pain,
who may be the most challenging to treat.
In treating patients postoperatively, surgeons must
strike a balance between meeting patient expectations for
pain control and responsible prescribing practices for the
good of society. Establishing a standard pain protocol for
speciﬁc surgical procedures can set expectations for patients
and can assist in identifying patients whose medication
requirements fall outside the expected range4. The ﬁndings of
this study can help to set such a protocol for knee arthroscopy
that meets patient expectations and minimizes surplus opioid
medication.
In conclusion, the median number of hydrocodone 5-mg
equivalent pills taken after knee arthroscopy is 7, with the
majority of patients consuming £20 pills. Meniscal repair,
smoking, and preoperative opioid usage were associated with
higher postoperative opioid consumption. n
NOTE: The authors thank Mr. Peter Dore for his assistance in the statistical analysis of this study.
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